Results

Total Results: 722 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

321. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/sensitivity-analysis-chapter-11.pptx
     January 01, 2013 - For example, when studying the association between thiazide diuretics and diabetes, one would presume … that the risk of incident diabetes among the “distant past users” should resemble that of the “nonusers … Therapies are often tested on an ideal population. … Important subpopulations include: - Pediatric populations: Children may respond differently to therapy … Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics

322. rheumatoid-arthritis-medicine-update-protocol-170515 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-update_research-protocol.pdf
     May 15, 2017 - Based on these findings, drug therapy may need to change at regular intervals until the treatment target … (progress from single therapy to combination therapy), (2) step down therapy (begin with combination … therapy and back down treatment when symptoms are under control), or (3) aggressively treat to target … to assess quantitatively whether the duration of disease in early RA modifies benefits or harms of treatments … Some examples of these uncertainties include the optimum order of therapeutics in early RA, and in patients

323. S5 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
     October 01, 2007 - The aims are to maximize the likelihood that beneficial treatments are used and that harmful treatments … misclassification), random er- ror, confounding by clinical conditions, indications for drugs, or use of other therapies … Medicaid data for research on the initiation, continuation, and patient outcomes of prescription drug therapies … Risk-adjustment esti- mates can provide information on treatment benefits for patients who received treatment … using a new diabetes medication.

324. Disposition of Comments for Screening for Glaucoma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_disposition-comments.pdf
     April 01, 2012 - Glauocma Medical Diagnosis and Therapy Volume One. Saunders. 2009 pp. 15-23. … As Pfizer’s efforts in this therapeutic area continue, we look forward to further collaboration with … the Agency on improving the body of clinical evidence for glaucoma and other important therapeutic … Glaucoma Medical Diagnosis and Therapy Volume One. Saunders. 2009 pp. 15-23. 2. … The report on treatment shows that there are effective treatments, so screening should be an aim of

325. S103 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s103.pdf
     October 01, 2007 - an individual been sub- jected to both treatments. … Supported by a Centers for Education and Research on Therapeutics coop- erative agreement (3 U18 HS010548 … In many studies, including studies involving surgery and expensive one-time therapies, the majority of … Williams & Wilkins S105 hypertension, cardiovascular disease, chronic obstructive pul- monary disease, diabetes … Estimating causal effects of treatments in randomized and nonrandomized studies.

326. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
     December 01, 2011 - These second-generation treatments include selective serotonin reuptake inhibitors (SSRIs: citalopram … Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … One trial showed that supplementing fluoxetine therapy with eszopiclone leads to improved sleep. … substance abuse, Alzheimer’s disease or other dementia, arthritis, cancer, coronary artery disease, diabetes … with the following comorbidities: alcohol/substance abuse, Alzheimer’s disease/dementia, arthritis, diabetes

327. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - It is not known whether these therapies are better or worse than other treatments for localized prostate … Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans … [ti] OR therapies[ti] OR treatment*[ti] OR treating[ti] OR treat[ti] OR therapy/mh AND Limits … Through 12/2005 Treatment with GnRH agonists was associated with increased risk of diabetes, coronary … It is not known whether these therapies are better or worse than other treatments for localized prostate

328. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - It is not known whether these therapies are better or worse than other treatments for localized prostate … Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans … [ti] OR therapies[ti] OR treatment*[ti] OR treating[ti] OR treat[ti] OR therapy/mh AND Limits … Through 12/2005 Treatment with GnRH agonists was associated with increased risk of diabetes, coronary … It is not known whether these therapies are better or worse than other treatments for localized prostate

329. Integrating Health System Data With Systematic Reviews_Methods Research Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-research-report-integrating-health-system-data.pdf
     April 01, 2020 - more than doubled the sample size;6 in another instance the local health system data on endovascular treatment … the data do not allow for evaluation of effects in important subgroups (e.g., large heterogeneity of treatment … Endovascular treatment of internal carotid artery bifurcation aneurysms: a single-center experience … Endovascular treatment of distal anterior cerebral artery aneurysms: single-center experience and a … clinical effectiveness and cost- effectiveness of different surveillance mammography regimens after the treatment

330. Methods-Guidance-Topics Methods (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topics_methods.pdf
     January 01, 2010 - Furthermore, beliefs about the advantages or disadvantages of various alternative treatments are an … the issues that underlie uncertainty about the comparative effectiveness of alternative tests or therapies … Diabetes mellitus. Functional limitations and disability. … What are the therapeutic aims of treatment? … What characteristics of the alternative treatments are likely to drive choices?

331. Executive Summary_Comparative Effectiveness Review No. 263: Management of Postpartum Hypertensive Disorders of Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-263-postpartum-hypertensive-pregnancy-executive-summary.pdf
     May 01, 2023 - rising in the United States,1, 2 likely due to increased prevalence of pre-existing HTN, obesity, diabetes … KQ 2: What are the effectiveness, comparative effectiveness, and harms of pharmacological treatments … treatments for postpartum HTN. … Five RCTs compared oral antihypertensive treatments for persistent postpartum HTN. … ) Outcome Category Outcome HBPM in PP Individuals Pharmacological Treatments for HDP in PP Individuals

332. Acs-Pci-Adjunctive-Devices Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-pci-adjunctive-devices_research-protocol.pdf
     July 01, 2010 - are undergoing PCI of native vessels, which patient characteristics (e.g., gender, age, ethnicity, diabetes … American College of Cardiology, European Society of Cardiology, and the Transcatheter Cardiovascular Therapeutics … quality criteria, study population, baseline patient characteristics, use of concurrent standard medical therapies … demographics (age, sex, and ethnicity), baseline patient health status (smoking history, history of diabetes … name Comparator Use of substandard alternative therapy Type of comparator Outcomes Intermediate end

333. Psoriasis-Chronic Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
     November 01, 2012 - modalities when making therapeutic decisions. … outcomes (mortality, HRQoL [e.g., DLQI, HAQ-DI, EQ-5D] and other patient-reported outcomes, MACE, diabetes … within the biologic, nonbiologic, and phototherapy treatments. … There was insufficient evidence to evaluate myocardial infarction and diabetes mellitus, and no other … Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

334. Coronary-Artery-Stenting Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
     February 01, 2013 - In determining the proper treatment course for patients with CAD, a number of treatment decisions must … The use of these adjunctive invasive procedures can also lead to additional invasive tests or treatments … were available online (through June 2012) from the following resources: Transcatheter Cardiovascular Therapeutics … was compared with optimal medical therapy only. … Treating low- risk lesions could lead to additional invasive tests or treatments that could adversely

335. Template for Draft Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
     October 06, 2006 - Other Arterial Revascularization Therapies Study (ARTS). Indian Heart J. 2001 Mar-Apr;53(2):239. … presence of diabetes. … Effects of coronary angioplasty, coronary bypass surgery, and medical therapy on employment in patients … Measuring the therapeutic efficacy of coronary revascularization: Implications for future management … Number of subjects who received assigned therapy?

336. Gout Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - Diabetes and gout: efficacy and safety of febuxostat and allopurinol. … Diabetes Obes Metab. 2013 Nov;15(11):1049-55. PMID: 23683134. 63. … The dynamics of chronic gout treatment: medication gaps and return to therapy. … Adherence with urate-lowering therapies for the treatment of gout. … between gout flares, time in treatment, serum uric acid level and urate lowering therapy.

337. Mindfulness-Based Interventions for Wellbeing and Mental Health in Children and Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amendment.pdf
     February 05, 2025 - Examples of other therapies include structured mindfulness programs and mindfulness-based therapies … , play therapy, dialectical behavior therapy, parent-child interaction therapy) and integrative therapies … , other treatments), and study results (outcomes). … treatments rather than other factors. … Mind-body therapies in children and youth.

338. Progestogens-Preterm-Birth Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
     September 01, 2012 - Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … limited to: • Complications during pregnancy (e.g. allergic reactions or development of gestational diabetes … frequency of administration, and gestational age at initiation or discontinuation of progestogen therapy … Modifiers of Outcomes by Cointerventions Ten studies with distinct populations reported using tocolytic treatments … Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled

339. Project Name: (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
     October 25, 2011 - The search criteria covered combination therapies. … using the various therapies are to be fully understood. … of patients, based on: race, gender, body mass index (BMI), existing non- insulin dependent diabetes … of patients, based on: race, gender, body mass index (BMI), existing non- insulin dependent diabetes … Furthermore, surgical treatment is often used in cases of failure of CPAP therapy and in those patients

340. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
     January 01, 2013 - regimen (i.e., repletion or continuous treatment) o Interactions between treatments (i.e., patients … regimen (i.e., repletion or continuous treatment) • Interactions between treatments (i.e., patients … regimen (i.e., repletion or continuous treatment) o Interactions between treatments (i.e., patients … 10 Abbreviations: CMS = Center for Medicare and Medicaid Services; NIDDK = National Institute of Diabetes … and clinical utility of iron status vary according to patients with different comorbidities (e.g., diabetes